Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400, Orsay, France.
Chem Soc Rev. 2024 Jun 17;53(12):6511-6567. doi: 10.1039/d2cs01060g.
Polymer prodrugs are based on the covalent linkage of therapeutic molecules to a polymer structure which avoids the problems and limitations commonly encountered with traditional drug-loaded nanocarriers in which drugs are just physically entrapped (, burst release, poor drug loadings). In the past few years, reversible-deactivation radical polymerization (RDRP) techniques have been extensively used to design tailor-made polymer prodrug nanocarriers. This synthesis strategy has received a lot of attention due to the possibility of fine tuning their structural parameters (, polymer nature and macromolecular characteristics, linker nature, physico-chemical properties, functionalization, ), to achieve optimized drug delivery and therapeutic efficacy. In particular, adjusting the nature of the drug-polymer linker has enabled the easy synthesis of stimuli-responsive polymer prodrugs for efficient spatiotemporal drug release. In this context, this review article will give an overview of the different stimuli-sensitive polymer prodrug structures designed by RDRP techniques, with a strong focus on the synthesis strategies, the macromolecular architectures and in particular the drug-polymer linker, which governs the drug release kinetics and eventually the therapeutic effect. Their biological evaluations will also be discussed.
聚合物前药是将治疗分子与聚合物结构共价连接,从而避免了传统载药纳米载体中常见的问题和限制,在传统载药纳米载体中,药物只是物理包埋(,爆发释放,药物负载率低)。在过去的几年中,可逆失活自由基聚合(RDRP)技术已被广泛用于设计定制的聚合物前药纳米载体。由于可以精细调整其结构参数(,聚合物性质和大分子特征,连接子性质,物理化学性质,功能化),这种合成策略受到了广泛关注,以实现优化的药物传递和治疗效果。特别是,通过调整药物-聚合物连接子的性质,可以轻松合成对刺激敏感的聚合物前药,从而实现高效的时空药物释放。在这方面,本文将概述 RDRP 技术设计的不同刺激敏感聚合物前药结构,重点介绍合成策略、大分子结构,特别是控制药物释放动力学并最终影响治疗效果的药物-聚合物连接子。还将讨论它们的生物学评价。